Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
TN2-M52H8 | Mouse | Mouse TNFR2 / CD120b / TNFRSF1B Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
TN2-H82E3 | Human | Biotinylated Human TNFR2 / CD120b / TNFRSF1B Protein, His,Avitag™ | ![]() |
![]() ![]() |
![]() ![]() |
TN2-H5227 | Human | Human TNFR2 / CD120b / TNFRSF1B Protein, His Tag | ![]() |
![]() ![]() |
![]() ![]() |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
SIM1811-03 | SIM0235; SIM1811-03 | Phase 1 Clinical | Jiangsu Xiansheng Pharmaceutical Co Ltd | Solid tumours; Lymphoma, T-Cell, Cutaneous | Details |
LBL-019 | LBL-019 | Phase 2 Clinical | Nanjing Leads Biolabs Co Ltd | Neoplasms | Details |
HFB-2003(HiFiBiO Therapeutics) | HFB-2003; HFB-200301 | Phase 1 Clinical | HiFiBiO Therapeutics | Stomach Neoplasms; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Mesothelioma; Sarcoma; Germinoma; Carcinoma, Non-Small-Cell Lung; Uterine Cervical Neoplasms; Melanoma | Details |
This web search service is supported by Google Inc.